<DOC>
	<DOCNO>NCT01435980</DOCNO>
	<brief_summary>Objectives : To investigate treatment effect Gastric Bypass Exenatide Type 2 Diabetes hospital , order investigate possible mechanism Gastric Bypass Exenatide .</brief_summary>
	<brief_title>Study Comparison Treatment Effect Between Gastric Bypass Exenatide Type 2 Diabetes</brief_title>
	<detailed_description>Methods : 60 Type 2 diabetes hospital divide 3 group : group A ( 20 patient give basal treatment ) , group B ( 20 patient give basal Exenatide treatment , group C（20 patient give basal Gastric Bypass treatment ) . The age , height , weight , blood glucose , glycosylated hemoglobin A1c（HbA1c） , homeostasis model assessment ( HOMA-IR ) , lipid , blood pressure , course disease , ejection fraction ( EF ) , fractional shortening ( FS ) , diameter leave ventricle late diastolic stage ( LVEDd ) , thickness ventricular septa（IVSD ) posterior wall right ventricle late diastolic stage ( LVPWd ) record respectively . Left ventricular mass index ( LVMI ) , relative wall thickness ( RWT ) calculate High-sensitive C-reactive protein ( HsCRP ) , adiponectin Tumor necrosis factor-α（TNF-α） detect Baseline . After group 's treatment , Change baseline index record , Multifactor logistic regression analyze correlation positive index .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>1 . BMI ≥ 35kg/m2 , With Type 2 Diabetes ; 2 . BMI3234.9kg/m2 , With Type 2 Diabetes , Insulin Therapy Combination With Oral Administration Drugs 6 Months HbA1c ≥ 7 % ; 3 . Between Ages 1860 Years ; 4 . Course Type 2 Diabetes ≤ 5 Years ; 5 . ICA , IAA , GAD Are Negative , Cpeptide Level Not Less Than 0.3mg / L ; 1. nondiabetic patient , type 1 diabetes ( serum insulin antibody ( ICA ) glutamic acid decarboxylase antibody ( GADA ) positive autoimmune diabetes ) , special type diabetes , gestational diabetes ; 2. patient liver renal failure 3. severe infection patient patient cerebrovascular disease 4. patient heart failure 5. fasting serum insulin 2hour postprandial serum insulin low normal ( &lt; 20mmol / L ) 6. course diabetes &gt; 5 year age &gt; 60 year age &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>Gastric Bypass</keyword>
	<keyword>GLP-1</keyword>
	<keyword>adiponectin</keyword>
</DOC>